| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/30/2009 | CA2702448A1 Method for purifying fc-fusion proteins |
| 04/30/2009 | CA2702333A1 Anti-ricin antibody |
| 04/30/2009 | CA2702248A1 Methods of inhibiting viral infection |
| 04/30/2009 | CA2701802A1 Compositions for detecting antibodies to babesia microti and methods of use thereof |
| 04/30/2009 | CA2700430A1 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | CA2695237A1 Anti-rantes antibodies and methods of use thereof |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2053129A2 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2053125A1 Streptococcus pyogenes antigens |
| 04/29/2009 | EP2053063A1 Recognition molecules for treatment and detection of tumours |
| 04/29/2009 | EP2053062A1 Immunoglobin variants outside the Fc region |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | EP2051997A1 Anti-c5ar antibodies with improved properties |
| 04/29/2009 | EP2051993A2 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 04/29/2009 | EP2051734A2 Agents for blood-brain barrier delivery |
| 04/29/2009 | EP1943276A4 Crystal structure of human urokinase plasminogen activator amino terminal fragment bound to its receptor |
| 04/29/2009 | EP1541686B1 CONSTRUCTION OF ANTIBODY USING MRL/lPR MOUSE |
| 04/29/2009 | EP1461357B1 Novel hev antigenic peptide and methods |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP0934083B1 Improved vaccines |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101421403A Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/29/2009 | CN101421395A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 04/29/2009 | CN101421305A Antibodies against insulin-like growth factor I receptor and uses thereof |
| 04/29/2009 | CN101421304A Affinity regions |
| 04/29/2009 | CN101421303A Improved protofibril selective antibodies and the use thereof |
| 04/29/2009 | CN101421302A Chimeric vaccine antigens against the avian influenza virus |
| 04/29/2009 | CN101421301A Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| 04/29/2009 | CN101421298A Novel composition and methods for the treatment of immune related diseases |
| 04/29/2009 | CN101420978A Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 04/29/2009 | CN101420977A NOGO receptor antagonists |
| 04/29/2009 | CN101420972A Methods for reducing protein aggregation |
| 04/29/2009 | CN101418045A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418044A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418043A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN100482797C Plant fatty acid epoxygenase genes and uses therefor |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482787C Immune colloid gold test paper strip for detecting sulfadiazine residue and its preparation method |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482285C Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ED-B |
| 04/29/2009 | CN100482277C Calicheamicin derivative-carrier conjugates |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/28/2009 | US7524939 Antibodies that bind to and inhibit human cytochrome P450 2C9*1, 2C9*2, and 2C9*3 |
| 04/28/2009 | US7524938 using a hapten comprising tetracarboxy phenyl porphyrin zinc or cobalt complexes, to generate monoclonal or polyclonal antibodies and testing for inhibitory effects of the antibodies on the gelatinase B; metalloenzyme inhibitors |
| 04/28/2009 | US7524937 Reducing body weight or food intake ; binding to antibody |
| 04/28/2009 | US7524936 labeled monoclonal or polyclonal antibodies that preferentially binds oxidoreductase enzyme polypeptides, proteins, fragments, domain peptides or amino acid sequences having replacements, capable of superoxide production |
| 04/28/2009 | US7524935 Sequences characteristic of hypoxia-regulated gene transcription |
| 04/28/2009 | US7524934 Human brain carboxypeptidase B antibodies |
| 04/28/2009 | US7524663 immunogens and epitopes used for treatment of autoimmune diseases; catalytic antibodies |
| 04/28/2009 | US7524654 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 04/28/2009 | US7524650 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524637 Nucleotide sequences coding g protein coupled receptors for identifying compounds block or enhance taste perception; food processing; improving taste of pharmeceuticals |
| 04/28/2009 | US7524635 Using hormone peptides concentrations as diagnostic tools in detection of cardiovascular disorders |
| 04/28/2009 | US7524628 Method for detecting molecules expressing a selected epitope via fluorescent dyes |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524622 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | US7524501 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
| 04/28/2009 | US7524500 Method of stimulating stem cells |
| 04/28/2009 | US7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/23/2009 | WO2009052439A2 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | WO2009052431A2 Cd19 binding agents and uses thereof |
| 04/23/2009 | WO2009052400A1 Antibodies that bind to mammalian ngal and uses thereof |
| 04/23/2009 | WO2009052392A1 Immunoassays and kits for the detection of ngal |
| 04/23/2009 | WO2009052374A2 Igm-mediated receptor clustering and cell modulation |
| 04/23/2009 | WO2009052293A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | WO2009052249A1 Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 04/23/2009 | WO2009052209A2 Isolation of stem cells and effective control of contamination |
| 04/23/2009 | WO2009052179A2 Feline pancreatic lipase |
| 04/23/2009 | WO2009052081A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | WO2009051277A1 Method for prediction of postoperative prognosis, and diagnosis kit |
| 04/23/2009 | WO2009051259A1 Biomarker for diagnosis of liver disease |
| 04/23/2009 | WO2009051220A1 Antibody capable of specifically binding to aβ oligomer, and use thereof |
| 04/23/2009 | WO2009051201A1 Anti-bst2 antibody |
| 04/23/2009 | WO2009051108A1 Method for production of antibody |
| 04/23/2009 | WO2009051078A1 Therapeutic gene expression system |
| 04/23/2009 | WO2009050453A2 Breast cancer associated antigen |
| 04/23/2009 | WO2009050446A1 Viral therapeutic |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050014A1 Methods for prediction of the therapeutic success of breast cancer therapy |
| 04/23/2009 | WO2009031818A3 Biomarker for purification or identification of mesenchymal stem cells and methods of purification of mesenchymal stem cells by using it |
| 04/23/2009 | WO2009031045A3 Anti-chikungunya monoclonal antibodies and uses thereof |
| 04/23/2009 | WO2009029235A3 Peptides and proteins for early liver development and anitibodies thereto, and their use in therapeutic diagnosis and treatment |
| 04/23/2009 | WO2009002939A3 Autophilic antibodies |
| 04/23/2009 | WO2009000098A3 Sequence based engineering and optimization of single chain antibodies |
| 04/23/2009 | WO2008154543A3 Methods for treating juvenile idiopathic arthritis |
| 04/23/2009 | WO2008143708A3 Methods and materials related to anti-amyloid antibodies |
| 04/23/2009 | WO2008140477A8 Hybrid immunoglobulins with moving parts |
| 04/23/2009 | WO2008134659A8 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 04/23/2009 | WO2008055072A3 Compositions and methods for treating ocular diseases and conditions |
| 04/23/2009 | WO2008021353A3 Composition and method for controlling hepatitis c virus infection |
| 04/23/2009 | WO2007146172A8 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 04/23/2009 | WO2007144893A3 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2007044887A3 Method for producing a population of homogenous tetravalent bispecific antibodies |
| 04/23/2009 | WO2007037669A3 Compositions for prevention and treatment of infections caused by eimeria parasites in animals |